NEW YORK, March 29 – Packard Biosciences has indefinitely postponed a planned follow-on offering of 10 million shares of its common stock, the company said Thursday.

The offering, which the company had announced in early February, is being postponed due to the downturn in the market, said Mike Zebarth, a company spokesman. Packard has filed an amended registration with the US Securities and Exchange Commission to reflect the change of plans.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.